Hyperacute Care Flashcards

What is hyperacute care?

Answer: Immediate care to stabilize and prevent further neurological damage

Hyperacute care refers to the critical and immediate medical management provided to stroke patients within the first few hours of symptom onset. The primary goal is to stabilize the patient, rapidly diagnose the type of stroke, and initiate treatments like thrombolysis or thrombectomy to restore blood flow or control bleeding. This minimizes brain damage and improves recovery prospects.

What is a common treatment in hyperacute care for ischemic stroke?

Answer: Thrombolytic therapy (tPA)

For ischemic stroke, which is caused by a blood clot blocking blood flow to the brain, thrombolytic therapy (tPA) is a primary treatment in hyperacute care. This medication works by dissolving the clot, thereby restoring crucial blood flow. Administered within a narrow time window, tPA aims to minimize brain damage and improve patient outcomes.

Why is monitoring of vital signs critical in hyperacute care?

Answer: To monitor for complications and stabilize the patient

In hyperacute stroke care, frequent monitoring of vital signs is crucial for detecting rapid changes in a patient's condition. It allows healthcare providers to identify potential complications like increased intracranial pressure, blood pressure fluctuations, or respiratory distress early. Prompt detection enables timely interventions to stabilize the patient and prevent further neurological damage.

What is the goal of hyperacute care for hemorrhagic stroke?

Answer: To stabilize the patient and control bleeding

Hemorrhagic stroke involves bleeding into the brain, rather than a clot. Therefore, the immediate goal in hyperacute care is to stabilize the patient's condition and control or stop the bleeding. This often involves managing blood pressure, reversing anticoagulation if applicable, and sometimes surgical intervention to relieve pressure or stop the hemorrhage.

What imaging technique is typically used in hyperacute care for stroke diagnosis?

Answer: CT scan

A CT scan is the imaging technique of choice in hyperacute stroke care due to its rapid availability and ability to quickly differentiate between ischemic and hemorrhagic stroke. This distinction is critical because treatment strategies differ significantly (e.g., tPA for ischemic vs. blood pressure control for hemorrhagic). While MRI provides more detailed images, it takes longer and is not typically the first-line diagnostic tool in the immediate hyperacute phase.

What is the role of neuroprotective strategies in hyperacute care?

Answer: To prevent further brain damage and improve outcomes

Neuroprotective strategies in hyperacute stroke care aim to protect brain cells from secondary injury following the initial stroke event. These strategies focus on minimizing damage to the penumbra, the area of brain tissue surrounding the core infarct that is at risk but not yet irreversibly damaged. By preserving this tissue, the goal is to limit the overall extent of brain injury and improve long-term functional outcomes.

What medication is commonly used for acute stroke patients to prevent complications?

Answer: Antiplatelet drugs

Antiplatelet drugs, such as aspirin, are commonly used for acute ischemic stroke patients (after ruling out hemorrhage) to prevent further clot formation and reduce the risk of early recurrent stroke. They work by inhibiting platelet aggregation, making the blood less likely to clot. This helps to maintain blood flow and prevent worsening of the ischemic event.

What is one of the immediate goals in hyperacute care for stroke patients?

Answer: To stabilize the patient and restore blood flow

The immediate goals in hyperacute stroke care are paramount for patient survival and minimizing disability. Stabilizing the patient involves managing vital signs and preventing secondary brain injury. For ischemic stroke, restoring blood flow to the brain via thrombolytics or thrombectomy is critical to salvage brain tissue within the narrow therapeutic window.

How does early administration of tPA affect patient outcomes?

Answer: It may improve functional outcomes in ischemic stroke

Early administration of tissue plasminogen activator (tPA) for eligible ischemic stroke patients is time-critical because it can dissolve the clot and restore blood flow to the brain. This re-perfusion, when achieved quickly, significantly increases the likelihood of improved functional outcomes and reduced disability. The benefit diminishes rapidly with time, highlighting the 'time is brain' principle.